These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 20515289)

  • 21. A comparison of ultrasound measurements to assess carotid atherosclerosis development in subjects with and without type 2 diabetes.
    Pollex RL; Spence JD; House AA; Fenster A; Hanley AJ; Zinman B; Harris SB; Hegele RA
    Cardiovasc Ultrasound; 2005 Jun; 3():15. PubMed ID: 15958169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coronary artery calcium outperforms carotid artery intima-media thickness as a noninvasive index of prevalent coronary artery stenosis.
    Terry JG; Carr JJ; Tang R; Evans GW; Kouba EO; Shi R; Cook DR; Vieira JL; Espeland MA; Mercuri MF; Crouse JR
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1723-8. PubMed ID: 15947237
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum dehydroepiandrosterone sulfate concentration and carotid atherosclerosis in men with type 2 diabetes.
    Fukui M; Kitagawa Y; Nakamura N; Kadono M; Yoshida M; Hirata C; Wada K; Hasegawa G; Yoshikawa T
    Atherosclerosis; 2005 Aug; 181(2):339-44. PubMed ID: 16039288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progression of calcified coronary atherosclerosis: relationship to coronary risk factors and carotid intima-media thickness.
    Taylor AJ; Bindeman J; Le TP; Bauer K; Byrd C; Feuerstein IM; Wu H; O'Malley PG
    Atherosclerosis; 2008 Mar; 197(1):339-45. PubMed ID: 17727858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Family history of coronary heart disease and markers of subclinical cardiovascular disease: where do we stand?
    Pandey AK; Pandey S; Blaha MJ; Agatston A; Feldman T; Ozner M; Santos RD; Budoff MJ; Blumenthal RS; Nasir K
    Atherosclerosis; 2013 Jun; 228(2):285-94. PubMed ID: 23578356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammation, atherosclerotic burden and cardiovascular prognosis.
    Espinola-Klein C; Rupprecht HJ; Bickel C; Lackner K; Schnabel R; Munzel T; Blankenberg S;
    Atherosclerosis; 2007 Dec; 195(2):e126-34. PubMed ID: 17336309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-18 levels are not associated with subclinical carotid atherosclerosis in a community population. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS).
    Chapman CM; McQuillan BM; Beilby JP; Thompson PL; Hung J
    Atherosclerosis; 2006 Dec; 189(2):414-9. PubMed ID: 16438977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of coronary artery calcium screening in subjects with and without diabetes.
    Raggi P; Shaw LJ; Berman DS; Callister TQ
    J Am Coll Cardiol; 2004 May; 43(9):1663-9. PubMed ID: 15120828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Assessment of the natural history of coronary artery calcification and identification of its determinants. Rationale of the 2nd part of the Heinz Nixdorf Recall Study].
    Möhlenkamp S; Moebus S; Schmermund A; Lehmann N; Hoffmann B; Neumann T; Stang A; Dragano N; Kerkhoff G; Naber C; Kälsch H; Beck EM; Bröcker-Preuss M; Kröger K; Budde T; Siegrist J; Mann K; Jöckel KH; Erbel R;
    Herz; 2007 Mar; 32(2):108-20. PubMed ID: 17401753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atherosclerosis imaging and calcified plaque: coronary artery disease risk assessment.
    Budoff MJ
    Prog Cardiovasc Dis; 2003; 46(2):135-48. PubMed ID: 14505288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of subclinical atherosclerosis and cardiovascular risk.
    Benitez RM; Vogel RA
    Clin Cardiol; 2001 Oct; 24(10):642-50. PubMed ID: 11594409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum bilirubin and genes controlling bilirubin concentrations as biomarkers for cardiovascular disease.
    Lin JP; Vitek L; Schwertner HA
    Clin Chem; 2010 Oct; 56(10):1535-43. PubMed ID: 20693308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Biomarkers in primary cardiovascular prevention: rationale, premises, and promises].
    Muscente F; De Caterina R
    G Ital Cardiol (Rome); 2017 Feb; 18(2):106-120. PubMed ID: 28398364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating cells as predictors of secondary manifestations of cardiovascular disease: design of the CIRCULATING CELLS study.
    Hoefer IE; Sels JW; Jukema JW; Bergheanu S; Biessen E; McClellan E; Daemen M; Doevendans P; de Groot P; Hillaert M; Horsman S; Ilhan M; Kuiper J; Pijls N; Redekop K; van der Spek P; Stubbs A; van de Veer E; Waltenberger J; van Zonneveld AJ; Pasterkamp G
    Clin Res Cardiol; 2013 Nov; 102(11):847-56. PubMed ID: 23975238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NEFRONA project: open-access database.
    Fernández E; Martínez Castelao A
    Nefrologia; 2011; 31(1):5-8. PubMed ID: 21270907
    [No Abstract]   [Full Text] [Related]  

  • 36. Adiponectin & inflammatory biomarkers in coronary artery disease.
    Oh J; Kang SM
    Indian J Med Res; 2014 Jun; 139(6):799-801. PubMed ID: 25228016
    [No Abstract]   [Full Text] [Related]  

  • 37. Cardiovascular Disease Risk Assessment: Review of Established and Newer Modalities.
    Tehrani DM; Wong ND
    Curr Treat Options Cardiovasc Med; 2015 Dec; 17(12):57. PubMed ID: 26472424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of the Adipokines as Biomarkers of Ischemic Cardiac Dysfunction.
    Mocan Hognogi LD; Goidescu CM; Farcaş AD
    Dis Markers; 2018; 2018():3406028. PubMed ID: 30405857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Framework for evaluating novel risk markers.
    Hlatky MA
    Ann Intern Med; 2012 Mar; 156(6):468-9. PubMed ID: 22431679
    [No Abstract]   [Full Text] [Related]  

  • 40. [Serum markers of coronary atherosclerosis].
    Masana Marín L
    Med Clin (Barc); 2007 Apr; 128(16):617-8. PubMed ID: 17524319
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.